Acasti Pharma Announces 1-for-6 Reverse Stock Split
/PRNewswire/ -- Acasti Pharma Inc. ("Acasti" or the "Company") (Nasdaq: ACST), a late-stage, biopharma company advancing GTX-104, its novel formulation of...
United States Robert Blum Prashant Kohli Exchange Commission Securities Exchange Computershare Services Inc
Source: prnewswire.com